Back to Search Start Over

Systemic Mastocytosis Associated with 'Smoldering' Multiple Myeloma

Authors :
Federica De Giorgi
Maurizio Zizzo
Andrea Palicelli
Magda Zanelli
Stefano Ascani
Stefano Ricci
Francesca Sanguedolce
Giovanni Martino
Source :
Diagnostics, Diagnostics, Vol 11, Iss 88, p 88 (2021)
Publication Year :
2021
Publisher :
MDPI AG, 2021.

Abstract

A 79-year-old woman presented with a long history of peripheral eosinophilia. Previous right hemicolectomy for colonic polyposis was reported. Laboratory tests were notable for mild macrocitic anaemia and eosinophilia. β2 microglobulin and serum tryptase levels were elevated. Serum immunofixation revealed IgA/kappa monoclonal protein. Bence-Jones protein was positive. Bone marrow (BM) biopsy revealed the coexistence of two neoplastic components. Cohesive clusters of bland-looking, spindle-shaped mast cells, representing 20% of marrow cellularity, were close to aggregates of mature plasma cells occupying 40% of marrow cellularity. Molecular analysis on marrow aspirate demonstrated KIT D816V mutation, TET2 mutation, monoallelic deletion of TP53/17p13 and trisomy of ATM/11q23. A bone density study revealed mild osteoporosis. Full skeletal X-rays and magnetic resonance imaging (MRI) of spine and hips showed multiple, small rarefaction areas and an old L1-L2 fracture, both ascribed to osteoporosis. The association of systemic mastocytosis (SM) and multiple myeloma (MM) is very uncommon. The coexistence of SM with MM placed our patient in the SM with associated clonal haematological non-mast-cell lineage disease (SM-AHN) subtype. Midostaurin therapy was started.

Details

ISSN :
20754418
Volume :
11
Database :
OpenAIRE
Journal :
Diagnostics
Accession number :
edsair.doi.dedup.....94bcf80540f575a5f0f68474d7fbbf2c
Full Text :
https://doi.org/10.3390/diagnostics11010088